These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9261262)

  • 1. D-dimer and anticoagulation in patients with mechanical prosthetic heart valves. A 2-year follow-up.
    Giansante C; Fiotti N; Calabrese S; La Verde R; Pandullo C; Scardi S; Guarnieri G
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1320-4. PubMed ID: 9261262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer to guide the intensity of anticoagulation in Chinese patients after mechanical heart valve replacement: a randomized controlled trial.
    Zhang L; Zheng X; Long Y; Wu M; Chen Y; Yang J; Liu Z; Zhang Z
    J Thromb Haemost; 2017 Oct; 15(10):1934-1941. PubMed ID: 28762606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between D-dimer levels and clinical events in patients with mechanical heart valve replacement under oral anticoagulation therapy].
    Zhang LT; Long YL; Yang J; Fan QK; Dai YY; Liu B; Zhang ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Oct; 45(10):852-856. PubMed ID: 29081174
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulation activation is associated with interleukin-6 plasma levels in patients with mechanical prosthetic heart valves.
    Liebe V; Kaden JJ; Isaaci S; Brueckmanni M; Hoffmann U; Bertsch T; Borggrefe M; Dempfle CE
    In Vivo; 2006; 20(3):427-30. PubMed ID: 16724683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of D-dimer and antithrombin-III levels in predicting prosthetic heart valve thrombosis.
    Nazli C; Kinay O; Tunc B; Ergene O; Gedikli O; Ayata A; Dogan A; Altinbas A; Ergene U; Ozaydin M; Yavuz T; Kahraman H
    Tex Heart Inst J; 2003; 30(4):268-79. PubMed ID: 14677736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-Dimer to Predict the Clinical Outcomes in Patients with Mechanical Heart Valve Replacement During Oral Anticoagulation Therapy.
    Zhang L; Long Y; Xiao H; Yang J; Liu X; Zhang Z
    Int Heart J; 2019 May; 60(3):631-636. PubMed ID: 31019170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Value of D-Dimer and INR in Patients Suspected to Have Prosthetic Valve Dysfunction.
    Moghadam RH; Salehi N; Rouzbahani M; Janjani P; Mahmoudi S; Izadpanah M; Heydarpour F; Shakiba E
    Braz J Cardiovasc Surg; 2022 Oct; 37(5):674-679. PubMed ID: 35244382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.
    Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R
    Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves.
    Acar J; Iung B; Boissel JP; Samama MM; Michel PL; Teppe JP; Pony JC; Breton HL; Thomas D; Isnard R; de Gevigney G; Viguier E; Sfihi A; Hanania G; Ghannem M; Mirode A; Nemoz C
    Circulation; 1996 Nov; 94(9):2107-12. PubMed ID: 8901659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aniticoagulation in patients following prosthetic heart valve replacement.
    Akhtar RP; Abid AR; Zafar H; Khan JS
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study.
    Poli D; Antonucci E; Pengo V; Migliaccio L; Testa S; Lodigiani C; Coffetti N; Facchinetti R; Serricchio G; Falco P; Mangione C; Masottini S; Ruocco L; De Caterina R; Palareti G;
    Int J Cardiol; 2018 Sep; 267():68-73. PubMed ID: 29957264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of markers of coagulation activation and reactive fibrinolysis in patients with mechanical heart valve prosthesis at different intensities of oral anticoagulation.
    van Wersch JW; van Mourik-Alderliesten CH; Coremans A
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):183-6. PubMed ID: 1606289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of D-dimer levels in patients with prosthetic valve thrombosis: relationship with thrombus burden and cerebrovascular events.
    Cerşit S; Gündüz S; Bayam E; Güner A; Kalkan S; Kalçık M; Karakoyun S; Gürsoy MO; Yesin M; Candan Ö; Özkan M
    Blood Coagul Fibrinolysis; 2018 Apr; 29(3):294-299. PubMed ID: 29570480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation activation and reactive fibrinolysis in patients receiving oral anticoagulation after total hip or knee replacement.
    van Wersch JW; de Vries-Hanje JC; Oosterbos C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):605-8. PubMed ID: 7841318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.
    Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation control quality affects the D-dimer levels of atrial fibrillation patients.
    Nakatani Y; Mizumaki K; Nishida K; Hirai T; Sakabe M; Oda Y; Joho S; Fujiki A; Nozawa T; Inoue H
    Circ J; 2012; 76(2):317-21. PubMed ID: 22185714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
    Lip GY; Lowe GD; Rumley A; Dunn FG
    Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty years' single-center experience with mechanical heart valves: a critical review of anticoagulation policy.
    Van Nooten GJ; Caes F; François K; Van Bellleghem Y; Bové T; Vandenplas G; Taeymans Y
    J Heart Valve Dis; 2012 Jan; 21(1):88-98. PubMed ID: 22474748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulation in carriers of mechanical heart valve prostheses: experience of ten years.
    Campos NL; Andrade RR; Silva MA
    Rev Bras Cir Cardiovasc; 2010; 25(4):457-65. PubMed ID: 21340374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement.
    Koertke H; Minami K; Boethig D; Breymann T; Seifert D; Wagner O; Atmacha N; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Circulation; 2003 Sep; 108 Suppl 1():II75-8. PubMed ID: 12970212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.